SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-022636
Filing Date
2024-02-29
Accepted
2024-02-29 07:06:26
Documents
101
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K amrn-20231231.htm   iXBRL 10-K 3477919
2 EX-10.43 amrn-ex10_43.htm EX-10.43 49098
3 EX-21.1 amrn-ex21_1.htm EX-21.1 17587
4 EX-23.1 amrn-ex23_1.htm EX-23.1 7645
5 EX-31.1 amrn-ex31_1.htm EX-31.1 14434
6 EX-31.2 amrn-ex31_2.htm EX-31.2 14658
7 EX-32.1 amrn-ex32_1.htm EX-32.1 11114
8 EX-97.1 amrn-ex97_1.htm EX-97.1 37689
9 GRAPHIC img152338051_0.jpg GRAPHIC 48445
10 GRAPHIC img152338051_1.jpg GRAPHIC 110257
  Complete submission text file 0000950170-24-022636.txt   14741431

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT amrn-20231231.xsd EX-101.SCH 1843977
103 EXTRACTED XBRL INSTANCE DOCUMENT amrn-20231231_htm.xml XML 2838554
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21392 | Film No.: 24698805
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)